Latest Headlines

  1. Meissner To Participate In ISPE's Annual Product Show

    Meissner will be exhibiting at ISPE’s Annual Product Show (Boston Chapter) on September 18, 2019, at Gillette Stadium, in Foxborough, MA.

  2. ABEC Sets Benchmark In Productivity For Flexible Biopharmaceutical Manufacturing

    ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, recently introduced the Flexible Manufacturing Platform, a fully customizable cell culture platform for flexible, high-volume biopharmaceutical production.

  3. ABEC Advances Single-Use Bioreactor Volumes To 6,000 Liters

    ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, recently announced the availability of Custom Single Run (CSR) Bioreactors with working volumes up to 6,000L.

  4. FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement For Biotherapeutic Development

    FUJIFILM Irvine Scientific, Inc., a world leader in the optimization, development and manufacture of cell culture media and industrial cell culture solutions, recently introduced BalanCD Gal Supplement.

  5. Biologics Modular Announces Issuance Of US Patent For Modular Cleanroom Facility

    Biologics Modular today announced a significant milestone with respect to intellectual property, demonstrating its ongoing commitment to innovation and leadership of the modular cleanroom industry. The patent award encompasses the area where cleanroom modules are preassembled with air filtration systems already in place.

  6. Batavia Biosciences To Deploy Horizon Discovery’s CHO Cell Technology To Develop anti-Zika Biotherapeutic With Vanderbilt University Medical Center And IDBiologics

    Recently, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines.

  7. Meissner To Present On The Evolution Of Fill And Finish Technology At BPI Boston/Biotech Week Boston

    Meissner will exhibit and present at BPI Boston, a part of Biotech Week Boston, which runs 9-12 September 2019, at The Boston Convention Center. Meissner’s Chief Science Officer, Christian Julien, will present on Wed. Sept. 11 @ 3:20PM in the exhibit hall’s Theater Showcase.

  8. Cognate BioServices Secures Capital Investment To Expand Commercial Manufacturing Capacity And Services For Cell Therapy Production

    Cognate BioServices, a leading contract development and manufacturing organization ("CDMO") in the global cellular therapies industry, announced today it has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW Healthcare Partners ("EW Healthcare").

  9. New Auto-Injector Pen Assembly Capabilities Compliment Fill-Finish Capabilities In North America And Europe

    Thermo Fisher recently expanded their steriles capabilities to support clients requiring auto-injector devices for patient self-administration.  Located in dedicated and flexible GMP-compliant cabins, Thermo Fisher can accommodate both small and multi-million unit runs. This further increases the company’s breadth of sterile services, which also includes cartridge and vial fill-finish, prefilled syringe assembly, primary and secondary packaging, and label services. 

  10. Thermo Fisher Scientific Launches Operator Training Using Virtual Reality In Greenville, NC

    Thermo Fisher will dedicate its newly installed training center, designed with industry-leading resources and technologies. The facility is equipped with virtual reality and augmented reality capabilities, which will mimic a real-world operating environment and equipment, and reduce the amount of training time by 50%.